Loading market dashboard
AnaptysBio, Inc.
ANABHealthcareNASDAQUS
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
AnaptysBio, Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $473.45M | $236.25M - $689.65M | -$347.25M | $7.151 | 3 |
| Dec 2029 | $359.57M | $179.43M - $523.77M | -$263.73M | $5.416 | 5 |
| Dec 2028 | $296.68M | $290.12M - $303.24M | -$217.60M | $5.261 | 6 |
| Dec 2027 | $172.04M | $154.52M - $189.55M | -$126.19M | -$2.343 | 4 |
| Dec 2026 | $123.99M | $33.35M - $214.65M | -$90.94M | -$2.035 | 4 |
| Dec 2025 | $205.27M | $153.50M - $234.08M | -$150.56M | -$0.964 | 9 |
| Dec 2024 | $55.91M | $47.36M - $63.12M | -$41.01M | -$4.056 | 9 |
| Dec 2023 | $30.47M | $15.21M - $44.39M | -$22.35M | -$6.343 | 5 |
| Dec 2022 | $9.05M | $5.84M - $13.40M | -$16.19M | -$4.526 | 2 |
| Dec 2021 | $63.17M | $40.78M - $93.51M | -$52.30M | -$1.833 | 3 |
| Dec 2020 | $95.00M | $61.33M - $140.63M | -$13.18M | $0.043 | 5 |
| Dec 2019 | $7.00M | $4.52M - $10.36M | -$5.80M | -$4.052 | 2 |